DSpace at Cardiff Met >

Browsing by Author Thomas, Andrew

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
1-Mar-2003Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitusThomas, Andrew; Anderson, R A; Evans, M; Smith, J C
2012The effects on markers of cellular stress and RAGE splicing in cellular models and in subjects receiving dietary CLA supplementationWebb, Richard; Thomas, Andrew; Mainwaring, Lowri
2012Identifying the characteristics for achieving sustainable manufacturing companiesThomas, Andrew; Francis, Mark; John, Elwyn; Davies, Alan
1-Nov-2002The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-naive patients with type 2 diabetesThomas, Andrew; Ahluwalia, M; Evans, M; Morris, K
2008Low-Intensity Exercise Exerts Beneficial Effects on Plasma Lipids via PPAR[gamma].Butcher, Lee; Thomas, Andrew; Backx, Karianne; Roberts, Aled; Webb, Richard; Morris, Keith
2009The Molecular Mechanisms Involved in Lipid Metabolism During Low Intensity ExerciseMorris, Keith; Thomas, Andrew; Backx, Karianne; Butcher, Lee
2009The Non-Genomic Effects Of The PPAR-γ Ligand Rosiglitazone On Intracellular Calcium Concentrations In Mammalian Monocytic And Smooth Muscle CellsWebb, Richard; Thomas, Andrew; Lang, Derek; Caddy, Joanne
1-Oct-2006Peripheral cytokine expression in autoimmune thyroiditis: Effects of in vitro modulation by rosiglitazone and dexamethasoneThomas, Andrew; Evans, L M; Okosieme, O E; Parkes, A B
1-Dec-2003Peroxisome proliferator-activated receptor-gamma agonists in atherosclerosis: current evidence and future directionsThomas, Andrew; Evans, M; Rees, A; Roberts, A W
Showing results 1 to 9 of 9


Valid XHTML 1.0! ???jsp.layout.footer-default.text.uwic??? Feedback